How is Cabotegravir Intramuscular Route dosed?
Cabotegravir injection is typically given as a shot into a muscle, usually in the buttocks, once a month for the first 2 months, then once every 2 months. The dosage and frequency of administration may vary depending on the individual's medical condition and response to treatment. Always follow your doctor's instructions for proper dosing and administration of the medication.
What is the dosage form of Cabotegravir Intramuscular Route?
Cabotegravir injection is available in the following dosage forms: Suspension, Extended Release.
What medications are contraindication with Cabotegravir Intramuscular Route?
Cabotegravir injection should not be used with seizure medications such as carbamazepine, oxcarbazepine, phenobarbital, phenytoin, Dilantin, Tegretol, Trileptal, or with medicines to treat tuberculosis like rifampin, rifapentine, Priftin, Rifadin, Rimactane. Combining these medicines with cabotegravir may reduce its effectiveness. Always consult your doctor before taking any medication to ensure safety and avoid potential interactions.
How is Cabotegravir Intramuscular Route administered?
Cabotegravir injection is administered intramuscularly, typically into the buttocks muscle. It is usually given once a month for the first 2 months, then once every 2 months. A nurse or other trained health professional will be responsible for providing the injection. Before receiving the injection, it is important to inform the healthcare provider about any allergies, liver or kidney disease, or HIV-1 infection. The injection comes with a patient information leaflet that should be read and followed carefully.
What are common precautions when taking Cabotegravir Intramuscular Route?
Common precautions when taking cabotegravir intramuscular route include:
- Allergies: Inform your doctor if you have had any allergic reactions to this medicine or any other medications.
- Kidney disease: Cabotegravir injection should be used with caution in patients with severe or end-stage kidney disease, as it may cause increased effects due to slower removal from the body.
- Liver disease: Use with caution in patients with liver disease, as it may exacerbate the condition.
- HIV-1 infection: This medicine should not be used in patients with HIV-1 infection, regardless of their status.
- Pediatric use: Safety and efficacy have not been established in children younger than 12 years of age or weighing less than 35 kilograms (kg).
- Geriatric use: Elderly patients may be more likely to have age-related kidney, liver, or heart problems, which may require caution when using this medicine.
- Breastfeeding: It is not known if cabotegravir is excreted in breast milk. Consult your doctor before breastfeeding while using this medicine. Follow your doctor's instructions and read the patient information leaflet carefully before receiving the injection. If you have any questions or concerns, consult your healthcare professional.